Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Poll - MDSpire

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

  • By

  • Chengqian Chen

  • Wei Guo

  • Xiaoyu Song

  • Xin Wan

  • Zhaoxia Li

  • Haotian Wang

  • Ou Bai

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

  • by Chengqian Chen, Wei Guo, Xiaoyu Song, Xin Wan, Zhaoxia Li, Haotian Wang, Ou Bai

  • May 29, 2026

Related Content

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Management of toxicities from antibody – drug conjugates in breast cancer